One-point decrease (improvement) | No change | One-point increase (worsening) | |
---|---|---|---|
DPNSS change for placebo group | 1 subject (3.6%) | 23 subjects (82.1%) | 4 subjects (14.2%) |
DPNSS change for DiVFuSS group | 13 subjects (33.3%) | 25 subject (64.1%) | 1 subject (2.6%) |
DiVFuSS, Diabetes Visual Function Supplement Study; DPNSS, Diabetic Peripheral Neuropathy Symptom Score.